Impact of Cardiac Resynchronization Therapy on Exercise Performance, Functional Capacity, and Quality of Life in Systolic Heart Failure With QRS Prolongation: COMPANION Trial Sub-Study

Journal of Cardiac Failure

Volumn 14, Issue 1, 2008, Pages 9-18

  De Marco, Teresa ^a   Wolfel, Eugene ^b   Feldman, Arthur M ^c   Lowes, Brian ^b   Higginbotham, Michael B ^d   Ghali, Jalal K ^e   Wagoner, Lynne ^f   Kirlin, Philip C ^g   Kennett, Jerry D ^h   Goel, Satish ⁱ   Saxon, Leslie A ^j   Boehmer, John P ^k   Mann, David ^l   Galle, Elizabeth ^m   Ecklund, Fred ^m   Yong, Patrick ⁿ   Bristow, Michael R ^b,m  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d DUKE UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^g METHODIST HOSPITAL   (United States)

^h Missouri Cardiovascular Specialists   (United States)

ⁱ BAPTIST MEDICAL CENTER   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^l Cardiovascular Associates   (United States)

^m Boston Scientific CRM   (United States)

ⁿ NONE

more..

Author keywords

6 minute walk distance; New York Heart Association functional class; Peak VO2

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY EXERCISE TEST; CLINICAL TRIAL; DEATH; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX; QUALITY OF LIFE; SINUS RHYTHM; SYMPTOMATOLOGY; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME; WALKING;

AGED; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PROBABILITY; QUALITY OF LIFE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 38349098526     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.08.003     Document Type: Article

References (24)

1. Cleland J.G., Thackray S., Goodge L., et al. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol 13 (2002) S73-S91
2. Executive summary: HFSA comprehensive heart failure practice guidelines. J Cardiac Fail 12 (2006) 10-38
3. ACC/AHA guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 46 (2005) 1116-1143
4. Packer M., and Cohn J.N. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 83 (1999) 1A-38A
5. Abraham W.T., Fischer W.G., Smith A.L., et al., for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
6. Young J.B., Abraham W.T., Smith A.L., et al., for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD trial. JAMA 289 (2003) 2685-2694
7. Cleland J.G.F., Daubert J.-C., Erdmann E., et al., for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
8. Higgins S.L., Hummel J.D., Niazi I.K., et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42 (2003) 1454-1459
9. Cazeau S., Leclercq C., Lavergne T., et al., for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
10. Auricchio A., Stellbrink C., Sack S., et al., for the Pacing Therapies in Congestive Heart failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39 (2002) 2026-2033
11. Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C., et al., Multisite stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
12. Bristow M.R., Saxon L.A., Boehmer J., et al., for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
13. Weber K.T., Kinasewitz G.T., Janicki J.S., and Fishman A.P. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 65 (1982) 1213-1223
14. Lipkin D., Scriven A.J., Crake T., and Poole-Wilson P.A. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 292 (1986) 653-655
15. Rector R.S., Kubo S.H., and Cohn J.N. Patients' self-assessment of their congestive heart failure. II. Content, reliability, and validity of a new measure-the Minnesota Living with Heart Failure questionnaire. Heart Fail 3 (1987) 198-209
16. Jennrich R.I., and Schlucter M.D. Unbalanced repeated measures models with structured covariance matrices. Biometrics 42 (1986) 805-820
17. Crawford S.L., Tennstedt S.L., and McKinlay J.B. A comparison of analytic methods for non-random missingness of outcome data. J Clin Epidemiol 48 (1995) 209-219
18. SAS System 9 Doc: SAS Online Doc 9.1.3. Available from: http://support.sas.com/onlinedoc/913/docMainpage.jsp. Accessed August 17, 2007.
19. Lavori P.W., Dawson R., and Shera D. A multiple imputation strategy for clinical trials with truncation of patient data. Stat Med 14 (1995) 1913-1925
20. Rubin D.B. Multiple imputation for non-response in surveys (1987), John Wiley & Son, Inc, New York
21. Middlekauff H.R. How does cardiac resynchronization therapy improve exercise capacity in chronic heart failure?. J Cardiac Fail 11 (2005) 534-541
22. Wilson J.R., Rayos G., Yeoh T.K., Gothard P., and Bak K. Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation 92 (1995) 47-53
23. St. John Sutton M.G., Plappert T., Abraham W.T., Smith A.L., Delergio D.B., Leon A.R., et al., Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
24. Kass D.A., Chen C.H., Curry C., Talbot M., Berger R., Fetics B., and Nevo E. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 99 (1999) 1567-1573